RE: Thin vol & large trade3 May 2024 16:29
Stock has been anchored to 1.6 for weeks
We require vol
More importantly all invested await the next update on CAR T …
Cogs will be turning
Prevail ain’t no naive muppets , they are a professional organisation who backed Hemos science & tossed a wedge in a lot higher than current stock price ,
I’m sure Vlad & Prevail are investigating all potential avenues for the benefit of Hemo & stockholders including Prevail .
Noted by Prevail in Sept RNS 👍
Mary Schaheen, President of Prevail Partners, stated: "Everyone at our fund is confident in the growth and success of Hemogenyx Pharmaceuticals as they develop CAR-T cells to target acute myeloid leukemia. Furthermore, Hemogenyx Pharmaceuticals has a seasoned management team with the expertise to accelerate the company to a significant value inflection point through the completion of its planned clinical trial."
News will flow & the stock will re rate imo
Have a superb weekend all invested & re group Tuesday morn